Magnetic Group Signaling (MGS®) Technology

Magnetic Group Signaling (MGS®) standardizes NMR systems and sample processing to ensure reproducible results on different NMR instruments.

Learn more

One Sample -

All Answers

Advanced. Automated. Affordable. Mastering Metabolite Networks for Real-Time Precision Medicine.

Learn more

AXINON® System

AXINON® is the first modular software-based system providing hardware, operating system, MGS® processor and individual test applications.

Learn more

Axinon system with implemented and expandable test overview

AXINON® System. |Precision Diagnostics. 

AXINON® is the first modular software-based system for clinical diagnostics - providing hardware, operating system, Magnetic Group Signaling (MGS®) processor and individual test applications, collectively enabling:

  •        Innovative real-time use of metabolic data
  •        Precise results for specific medical questions and diagnostic decisions
  •        Standardized analysis
  •        Multi-testing flexibility
  •        High throughput capability
  •                Fully automated lab solution
  •                High reproducibility (inter-laboratory precision)
  •                Connectivity to lab systems (LIS/LIMS)
  •                Easy-to-use
Axinon system with implemented and expandable test overview

Platform

The NMR based AXINON® System offers high throughput multi-testing capability

Precision

AXINON® enables a more detailed, standardized and automated lipoprotein and metabolite profiling

Performance

Identification of more than 400 metabolites within one run enables the discovery of meaningful metabolite constellations/profiles

numares licenses AXINON® Software, Magnetic Group Signaling (MGS®) technology and research methods/applications underlying our diagnostic products* to customers of the healthcare industry. For an individual licensing agreement, contact us.

Magnetic Group Signaling. |Next Generation of NMR Use.

Magnetic Group Signaling (MGS®) is the core of the AXINON® System. MGS® enables AXINON® to reproducibly elucidate metabolite constellations using nuclear magnetic resonance (NMR) spectroscopy. This enables NMR use for diagnostic purposes.

  • Standardized algorithms based on Artificial Intelligence (AI)
  • Reproducible multivariable signal fitting
  • Quantitative multi-signal interpretation
  • Validated extraction of information from NMR spectra
  • Sophisticated SCORE calculation 
 

“With MGS®, we evolved NMR to a fully automated  system applicable to routine analysis. It enables diagnostics with excellent precision and comparability. MGS®-generated data can be analysed by several other AXINON® tests and reveal new diagnostic information.”

Dr. Daniela Baumstark

Head of Lipoprotein Analysis and Data Processing

Identifying Metabolites with AI-Enabled Technology

Finding metabolite constellations among hundreds of signals is not easy.

Using machine learning:

  • We analyze study data together with NMR metabolite measurements to identify which biomarkers carry the most information about a particular disease.
  • We then build an equation representing the metabolite constellation, using the equation as a diagnostic test in our products.

Machine learning:

  • Includes a number of methods in the artificial intelligence field.
  • Sophisticated statistical algorithms use labeled examples of healthy and ill individuals to identify the signals separating the two (“learning the difference”).
  • The resulting models from this metabolite constellation can then predict whether a patient is healthy or ill.

Our German engineering:

  • Highly skilled statisticians ensure expert use of machine learning algorithms, combined with our biochemists' knowledge to guide the machine learning process with human knowledge.
  • When we combine the strengths of human and machine, we're enabling the best possible results.
  • These precision results can then be interpreted by physicians.

* For Research Use only in the United States. numares’ products are not yet available for sale within the United States; they have not yet been approved or cleared by the U.S. Food and Drug Administration.

Video Tutorials

numares' video tutorials provide user support for the AXINON® System in installation, handling and maintenance of AXINON® Software, NMR (nuclear magnetic resonance spectroscopy) hardware and diagnostic software test applications.

For questions, contact Technical Support.

DAILY NMR Maintenance and Qualification

 
Learn how to monitor the Liquid Nitrogen Levels of the NMR spectrometer of the AXINON System*. This version is without audio comments. - only for trained personnel -
 
Learn how to check the gradient image in NMR spectroscopy of the AXINON System*. This version is without audio comments. - only for trained personnel -
 
Learn how to check for noise in NMR spectroscopy of the AXINON System*. This version is without audio comments. - only for trained personnel -
 
Learn how to check the temperature of SampleJet cooling positions of the AXINON System*. This version is without audio comments. - only for trained personnel -
 
Learn how to check the status of the NMR console of the AXINON System*. This version is without audio comments. - only for trained personnel -

Further NMR Maintenance Video Tutorials

 
Learn how easy NMR diagnostics can be performed in high-throughput with the AXINON system*. This version is without audio comments. - only for trained personnel -
 
Learn how easy NMR diagnostics can be performed with the AXINON system*. This version is without audio comments. - only for trained personnel -
 
Learn how to reboot the AXINON System*. This version is without audio comments. - only for trained personnel –
 
Learn how to exchange the NMR pincer*. This version is without audio comments. - only for trained personnel –
 
Learn how to clean the NMR probe*. This version is without audio comments. - only for trained personnel –

* For Research Use only in the United States. numares’ products are not yet available for sale in the United States and are not yet approved or cleared by the U.S. Food and Drug Administration.

You did not activate the necessary cookies for this content.

activate necessary cookies and show content